TOKYO: Japanese stocks fell on Thursday as fading hopes for a new round of US fiscal stimulus, a return of coronavirus lockdowns in Europe and worries about Sino-US tensions hurt sentiment. The Nikkei index ended 0.51% lower at 23,507.23, with the healthcare and telecommunications sectors leading the decline. The broader Topix fell 0.74% to 1,631.79.

The biggest underperformers among the top 30 core Topix names were venture capitalist SoftBank Group Corp, down 2.08%, followed by drugs maker Takeda Pharmaceutical Co Ltd losing 1.97%. The stocks that gained the most among Topix 30 were electronic parts maker Murata Manufacturing Co Ltd, up 1%, followed by industrial conglomerate Mitsubishi Corp gaining 0.42%.

There were 64 advancers on the Nikkei index against 156 decliners. The volume of shares traded on the Tokyo Stock Exchange's main board was 0.89 billion, compared with the average of 1.11 billion in the past 30 days.

US Treasury Secretary Steve Mnuchin said reaching a compromise with the Democrats on a fiscal stimulus was unlikely before the Nov. 3 election, raising concerns about the economic outlook for an economy reeling from the impact of the Covid-19 pandemic.

Sentiment also worsened after sources told Reuters the US State Department has submitted a proposal for President Donald Trump administration to add China's Ant Group to a trade blacklist, which could complicate its highly-anticipated initial public offering.

Britain has introduced a new lockdown system, France imposed curfews and other European nations were closing schools to stop a second wave of the novel coronavirus. "We believe the momentum underlying the current recovery will slow down gradually," Soichiro Matsumoto, chief investment officer for Japan at Credit Suisse, wrote in a memo.